HLA Polymorphisms Predict NY-ESO-1 Tumor Antigen Serology and Overall Survival in Epithelial Ovarian Cancer

被引:0
|
作者
Daudi, Sayeema [1 ]
Brady, Mark [1 ]
Miliotto, Tony [1 ]
Matsuzaki, Junko [1 ]
Lele, Shashikant [1 ]
Odunsi, Kunle [1 ]
机构
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:86A / 86A
页数:1
相关论文
共 50 条
  • [31] Development of a transient mammalian expression process for the production of the cancer testis antigen NY-ESO-1
    Hacker, David L.
    Cohen, Leonard
    Muller, Natahe
    Thanh, Huy-Phan
    Derow, Elisabeth
    Ritter, Gerd
    Wurm, Florian M.
    CELL TECHNOLOGY FOR CELL PRODUCTS, 2007, : 455 - +
  • [32] Development of a transient mammalian expression process for the production of the cancer testis antigen NY-ESO-1
    Hacker, David L.
    Cohen, Leonard
    Muller, Natalie
    Thanh, Huy-Phan
    Derow, Elisabeth
    Ritter, Gerd
    Wurm, Florian M.
    CELL TECHNOLOGY FOR CELL PRODUCTS, 2007, : 125 - +
  • [33] HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancer
    Sonpavde, Guru
    Wang, Mingjun
    Peterson, Leif E.
    Wang, Helen Y.
    Joe, Teresa
    Mims, Martha P.
    Kadmon, Dov
    Ittmann, Michael M.
    Wheeler, Thomas M.
    Gee, Adrian P.
    Wang, Rong-Fu
    Hayes, Teresa G.
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (02) : 235 - 242
  • [34] Development of a TCR-like antibody and chimeric antigen receptor against NY-ESO-1/HLA-A2 for cancer immunotherapy
    Liu, Xin
    Xu, Yixiang
    Xiong, Wei
    Yin, Bingnan
    Huang, Yuqian
    Chu, Junjun
    Xing, Changsheng
    Qian, Chen
    Du, Yang
    Duan, Tianhao
    Wang, Helen Y.
    Zhang, Ningyan
    Yu, John S.
    An, Zhiqiang
    Wang, Rongfu
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (03)
  • [35] Oncolytic attenuated measles virus encoding NY-ESO-1 induces HLA I and II presentation of this tumor antigen by melanoma and dendritic cells
    Grard, Marion
    Idjellidaine, Mohamed
    Arbabian, Atousa
    Chatelain, Camille
    Berland, Laurine
    Combredet, Chantal
    Dutoit, Soizic
    Deshayes, Sophie
    Dehame, Virginie
    Labarriere, Nathalie
    Fradin, Delphine
    Boisgerault, Nicolas
    Blanquart, Christophe
    Tangy, Frederic
    Fonteneau, Jean-Francois
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (10) : 3309 - 3322
  • [36] Oncolytic attenuated measles virus encoding NY-ESO-1 induces HLA I and II presentation of this tumor antigen by melanoma and dendritic cells
    Marion Grard
    Mohamed Idjellidaine
    Atousa Arbabian
    Camille Chatelain
    Laurine Berland
    Chantal Combredet
    Soizic Dutoit
    Sophie Deshayes
    Virginie Dehame
    Nathalie Labarrière
    Delphine Fradin
    Nicolas Boisgerault
    Christophe Blanquart
    Frédéric Tangy
    Jean-François Fonteneau
    Cancer Immunology, Immunotherapy, 2023, 72 : 3309 - 3322
  • [37] HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancer
    Guru Sonpavde
    Mingjun Wang
    Leif E. Peterson
    Helen Y. Wang
    Teresa Joe
    Martha P. Mims
    Dov Kadmon
    Michael M. Ittmann
    Thomas M. Wheeler
    Adrian P. Gee
    Rong-Fu Wang
    Teresa G. Hayes
    Investigational New Drugs, 2014, 32 : 235 - 242
  • [38] Expression in childhood primary brain tumors of NY-ESO-1, a cancer/testis antigen: An immunohistochemical study
    Bodey, Bela
    Bodey, Vivian
    Siegel, Stuart E.
    IN VIVO, 2008, 22 (01): : 83 - 87
  • [39] IHC and RT-PCR assays for detection of cancer antigen NY-ESO-1 in human tissues
    Halim, Abdel
    Bagley, Rebecca G.
    Dauffenbach, Lisa
    Olsen, Eric P.
    Keler, Tibor
    CANCER RESEARCH, 2016, 76
  • [40] NY-ESO-1/LAGE-1 tumor associated antigen expression in clinical samples: a tissue microarray study
    Bolli, M
    Adamina, M
    Schultz-Thater, E
    Guller, U
    Oertli, D
    Spagnoli, GC
    Heberer, M
    BRITISH JOURNAL OF SURGERY, 2004, 91 (07) : 903 - 904